Atezolizumab - Globe Thesis

Keyword [Atezolizumab] Result: 1 - 14 \| Page: 1 of 1
1.	Case Report Of PD-L1 Monoclonal Antibody For Treating Advanced Lung Adenocarcinoma
2.	Computational Design Of IgG-like Bispecific Antibodies Targeting EGFR And PD-L1
3.	A Retrospective Cohort Study To Explore The Correlation Between Peripheral Blood Markers And Survival In Solid Tumor Treated With Atezolizumab Monotherapy
4.	Antitumor Effect Of Macrophage Polarization And Immunotherapy Of Atezolizumab In Humanized Bladder Cancer Mouse Model
5.	Functional Activity Of Humanized PD-L1 Monoclonal Antibody And Its Toxic Effects On Human Lung Adenocarcinoma Cell Line HCC827
6.	Efficacy And Treatment-related Toxicities Associated With PD-1/PD-L1 Inhibitors In Previously-treated Advanced Non-small Cell Lung Cancer(NSCLC):Systematic Review And Meta-analysis
7.	Incidence And Risk Of PD-1/PD-L1 Inhibitors Related Pneumonitis In Patients With Advanced Cancer
8.	Atezolizumab Alleviates Immunosuppression Induced By PD-L1~+ Neutrophils During Sepsis
9.	Cost-effectiveness Analysis Of Atezolizumab As First-line Treatment For Advanced Urinary Tumor
10.	Efficacy And Immune-Related Adverse Events Induced By PD-1/PD-L1 Inhibitors As First-Line Treatment For Advanced Non-Small Cell Lung Cancer:a Meta-Analysis Of Randomized Controlled Trials
11.	Cost-utility Analysis Of PD-1/PD-L1 Inhibitors As First-line Treatment For Advanced Lung Cancer
12.	Combination Of EP And Anti-PD-1 Pathway Or Anti-CTLA-4 For The Phase ? Trial Of Small Cell Lung Cancer:A Meta-analysis
13.	First-line Treatment With Atezolizumab Plus Nab-paclitaxel For Advanced Triple-negative Breast Cancer: A Cost-utility Analysis
14.	Efficacy And Safety Of PD-1/PD-L1 Inhibitors Plus Chemotherapy For Triple Negative Breast Cancer:A Systematic Review And Meta-analysis
<<First <Prev Next> Last>> Jump to